Sinopharm Group Co. Ltd.

In 2024, Sinopharm Group Co. Ltd. reported total emissions of approximately 544,381,900 kg CO2e. This included Scope 1 emissions of approximately 48,785,710 kg CO2e, Scope 2 emissions of approximately 177,259,360 kg CO2e, and Scope 3 emissions of approximately 318,336,830 kg CO2e.

Looking back, in 2023, the company disclosed Scope 1 emissions of around 54,715,050 kg CO2e and Scope 2 emissions of approximately 208,700,220 kg CO2e, totalling about 263,415,270 kg CO2e for Scope 1 and 2. In 2022, Scope 1 emissions were approximately 52,434,340 kg CO2e and Scope 2 emissions were about 200,670,940 kg CO2e. For 2021, Sinopharm Group Co. Ltd. reported Scope 1 emissions of roughly 51,430,120 kg CO2e and Scope 2 emissions of approximately 164,261,330 kg CO2e, with a combined total of around 215,691,450 kg CO2e. In 2020, the company's Scope 1 emissions were about 52,946,470 kg CO2e and Scope 2 emissions were roughly 155,266,590 kg CO2e, leading to a total of approximately 208,213,060 kg CO2e for Scope 1 and 2. In 2019, Scope 1 emissions were around 37,435,630 kg CO2e and Scope 2 emissions were about 105,924,730 kg CO2e. In 2018, Scope 1 emissions stood at approximately 30,741,540 kg CO2e and Scope 2 emissions at roughly 88,611,470 kg CO2e.

Sinopharm Group Co. Ltd. has set a near-term target to achieve net-zero Scope 1 and Scope 2 emissions by 2030, with a baseline year of 2023. Additionally, cascaded from its ultimate parent, SDIC, there are long-term net-zero targets for Scope 1 and Scope 2 emissions by 2050, based on a 2018 baseline.